new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Arena Pharmaceuticals Inc
Arena Pharmaceuticals Inc_20100107
  

Arena Pharmaceuticals Inc patents

Recent patent applications related to Arena Pharmaceuticals Inc. Arena Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Arena Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Arena Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Arena Pharmaceuticals Inc-related inventors




Date Arena Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
04/06/17Non-hygroscopic salts of 5-ht2c agonists
03/02/17Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
03/02/17Substituted pyridazines as prostacyclin receptor modulators
12/29/16Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
11/03/161-heteroaryl-indoline-4-carboxamides as modulators of gpr52 useful for the treatment or prevention of disorders related thereto
10/20/163-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
09/22/16Cannabinoid receptor modulators
09/22/16Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
09/01/165ht2c receptor modulators
06/30/16Processes for preparing 3-benzazepines
06/02/16Salts of lorcaserin with optically active acids
03/17/16Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
03/17/16Methods of identifying candidate compounds of the human g protein-coupled receptor, gpr50, as modulators of body mass or adiposity
01/21/16Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
01/14/16Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
12/10/15Biphenyl-ethyl-pyrrolidine derivatives as histamine h3 receptor modulators for the treatment of cognitive disorders
11/26/15Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
11/26/15Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
10/22/15Method of weight management
10/08/15Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof
09/24/15Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
07/16/15Administration of an anti-obesity compound to individuals with renal impairment
07/09/15Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
06/25/15Ethers, secondary amines and derivatives thereof as modulators of the 5-ht 2a serotonin receptor useful for the treatment of disorders related thereto
06/04/15Endogenous and non-endogenous versions of human g protein-coupled receptors
12/04/14Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
09/11/14Human g protein-coupled receptor and modulators thereof for the treatment of atherosclerosis and atherosclerotic disease and for the treatment of conditions related to mcp-1 expression
08/21/14Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
06/19/14Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
06/12/14Ethers, secondary amines and derivatives thereof as modulators of the 5-ht 2a serotonin receptor useful for the treatment of disorders related thereto
05/29/14Fast-dissolve dosage forms of 5-ht2c agonists
03/06/14Modulators of the gpr119 receptor and the treatment of disorders related thereto
02/20/14Modulators of the gpr119 receptor and the treatment of disorders related thereto
02/20/14Modulators of the gpr119 receptor and the treatment of disorders related thereto
02/06/14Modulators of the gpr119 receptor and the treatment of disorders related thereto
01/16/14Modulators of the gpr119 receptor and the treatment of disorders related thereto
11/21/13Salts of lorcaserin with optically active acids
11/21/13Endogenous and non-endogenous versions of human g protein-coupled receptors
10/10/135-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level
09/12/13Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
08/22/135ht2c receptor modulator compositions and methods of use
08/22/13Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
08/22/13Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
07/18/13Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
07/11/13Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
07/04/13Benzazepine derivatives useful for treatment of 5ht2c receptor associated diseases
06/20/13Processes for the preparation of 5-ht2c receptor agonists
05/23/13Methods of using a g protein-coupled receptor to identify peptide yy (pyy) secretagogues and compounds useful in the treatment of conditions modulated by pyy
03/28/13Combination therapy for the treatment of obesity and diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
01/24/13Modulators of the gpr119 receptor and the treatment of disorders related thereto
01/24/131,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
12/27/12Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof
11/22/12Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
09/06/12Crystalline forms and processes for the preparation of pg12 receptor agonists
05/31/125ht2c receptor modulators
03/08/12Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual
12/08/11Systems and methods for computer assisted alignment of conformers
10/27/11Imidazo[1,2-a]pyridine derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
10/06/11Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
09/15/11Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
08/25/11Composition of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto
08/11/11Human orphan g protein-coupled receptors
06/02/11Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
05/12/111,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
04/07/111,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
Patent Packs
03/03/11Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
02/17/11Processes useful for the synthesis of (r)-1--2-methyl-pyrrolidine
01/27/11Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
12/30/10Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto
11/25/10Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/18/10Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/18/10Dihydro-1h-pyrrolo[1,2-a]indol-1-yl carboxylic acid derivatives which act as s1p1 agonists
11/18/10Crystalline forms of (r)-1-{2-[4`- (3-methoxy-propane-1- sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, and compositions, and methods related thereto
11/11/10Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/11/10Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/11/10Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/11/10Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/11/10Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/11/10Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
10/28/10Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
Patent Packs
09/16/10Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
08/19/10Methods of using a g protein-coupled receptor to identify peptide yy (pyy) secretagogues and compounds useful in the treatment of conditions modulated by pyy
08/12/10Methods of using gpr119 to identify compounds useful for increasing bone mass in an individual
08/12/10Methods of using gpr119 to identify compounds useful for increasing bone mass in an individual
08/12/10Methods of using a g protein-coupled receptor to identify peptide yy (pyy) secretagogues and compounds useful in the treatment of conditions modulated by pyy
08/12/10Methods of using gpr119 to identify compounds useful for increasing bone mass in an individual
07/29/10Gpr119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto
07/08/10Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
06/24/10Modulators of metabolism and the treatment of disorders related thereto
06/03/10Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
04/15/10Gpr43 and modulators thereof for the treatment of metabolic-related disorders
04/15/10Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
02/25/10Endogenous and non-endogenous versions of human g protein-coupled receptors
01/07/10Modulators of metabolism and the treatment of disorders related thereto
11/19/09Modulators of metabolism and the treatment of disorders related thereto
10/15/09Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
10/08/09Methods of using a g protein-coupled receptor to identify peptide yy (pyy) secretagogues and compounds useful in the treatment of conditions modulated by pyy
08/06/09Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
07/23/09Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
02/05/09Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
02/05/09Pyrimidine derivatives and methods of treatment related to the use thereof
01/07/10Modulators of metabolism and the treatment of disorders related thereto







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Arena Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Arena Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';